• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素A在大鼠体内可能存在剂量依赖性药代动力学的证据。

Evidence for a possible dose-dependent pharmacokinetics of Cyclosporin-A in the rat.

作者信息

Nooter K, Schultz F, Sonneveld P

出版信息

Res Commun Chem Pathol Pharmacol. 1984 Mar;43(3):407-15.

PMID:6718808
Abstract

Cyclosporin-A (Cy-A) was administered to rats intravenously (i.v.) at different dosages (20, 40 and 80 mg/kg body weight). At the lower dose (20 mg/kg), the blood levels decreased biphasically and could be described by an open linear two-compartment model with excretion from the central compartment only. The t 1/2 values for the alpha-distribution and beta-elimination phases were about 6 min and 16.5 h, respectively. At higher dose levels (40 and 80 mg/kg), the involvement of an additional compartment became apparent. The blood concentration/time data sets obtained with 40 and 80 mg/kg doses were best described by an open linear three-compartment model. The 24-h urine and bile excretions were in the order of 10 and 20% of the total administered dose. The values for the normalized areas under the plasma concentration/time curves obtained at different Cy-A doses (20, 40 and 80 mg/kg) were about 1, 3 and 25, respectively.

摘要

将环孢素 A(Cy - A)以不同剂量(20、40 和 80 毫克/千克体重)静脉注射给大鼠。在较低剂量(20 毫克/千克)时,血药浓度呈双相下降,可用仅从中央室排泄的开放线性二室模型描述。α分布相和β消除相的 t1/2 值分别约为 6 分钟和 16.5 小时。在较高剂量水平(40 和 80 毫克/千克)时,另一个房室的参与变得明显。40 和 80 毫克/千克剂量获得的血药浓度/时间数据集最好用开放线性三室模型描述。24 小时尿液和胆汁排泄量约为总给药剂量的 10%和 20%。在不同 Cy - A 剂量(20、40 和 80 毫克/千克)下获得的血浆浓度/时间曲线下归一化面积值分别约为 1、3 和 25。

相似文献

1
Evidence for a possible dose-dependent pharmacokinetics of Cyclosporin-A in the rat.环孢素A在大鼠体内可能存在剂量依赖性药代动力学的证据。
Res Commun Chem Pathol Pharmacol. 1984 Mar;43(3):407-15.
2
Oral and intravenous trichloroethylene pharmacokinetics in the rat.
J Toxicol Environ Health. 1985;15(5):587-601. doi: 10.1080/15287398509530688.
3
Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.1-(2-脱氧-β-D-呋喃核糖基)-2,4-二氟-5-碘苯的剂量依赖性药代动力学:一种潜在的5-碘-2'-脱氧尿苷模拟物
Biopharm Drug Dispos. 2003 Dec;24(9):385-95. doi: 10.1002/bdd.375.
4
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.新型促甲状腺素释放激素类似物水合蒙替瑞林的药代动力学。首次通讯:对大鼠、狗和猴子单次静脉给药后的血浆浓度、代谢及排泄情况
Arzneimittelforschung. 1996 Feb;46(2):106-13.
5
The dose-dependent fate of 1,4-dioxane in rats.
J Environ Pathol Toxicol. 1978 Nov-Dec;2(2):263-82.
6
Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
Drug Metab Dispos. 1993 Jan-Feb;21(1):189-93.
7
Application of the two-compartment open model with Michaelis-Menten elimination kinetics to valproic acid in the bile-exteriorized rat.具有米氏消除动力学的二室开放模型在胆管外引流大鼠丙戊酸研究中的应用。
Res Commun Chem Pathol Pharmacol. 1980 Mar;27(3):469-84.
8
Serum disappearance and urinary excretion of sulfamethoxypyridazine in goats.磺胺甲氧嗪在山羊体内的血清消除及尿排泄情况
Rev Elev Med Vet Pays Trop. 1994;47(2):215-8.
9
Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.9-硝基-20(S)-喜树碱在大鼠体内的药代动力学
Acta Pharmacol Sin. 2003 Mar;24(3):256-62.
10
Pharmacokinetics of tryptamide following intravenous administration in rats.大鼠静脉注射色胺后的药代动力学
Pol J Pharmacol Pharm. 1991 Jan-Feb;43(1):21-5.

引用本文的文献

1
Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.环孢素的药代动力学:持续静脉输注速率对肾移植患者的影响。
Br J Clin Pharmacol. 1987 Oct;24(4):519-26. doi: 10.1111/j.1365-2125.1987.tb03206.x.
2
On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers.
J Pharmacokinet Biopharm. 1988 Aug;16(4):331-53. doi: 10.1007/BF01062550.